Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | CCR6 | P51684 | 1/20 | 0.50 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11858419 | 0.92 | ALDH1A1 (0.53) | ALDH1A1KDM4EKMT2AMEN1NPC1 | |
| SCHEMBL10573661 | 0.85 | MEN1 (0.69) | ALDH1A1KMT2AMEN1NPC1PKM | |
| SCHEMBL11574390 | 0.84 | KMT2A (0.63) | ALDH1A1KMT2AMEN1NPC1PKM | |
| SCHEMBL2071222 | 0.84 | KMT2A (0.63) | ALDH1A1KMT2AMEN1NPC1PKM | |
| SCHEMBL989364 | 0.83 | ALDH1A1 (0.67) | ALDH1A1KDM4EKMT2AMEN1NPC1 | |
| SCHEMBL7918663 | 0.81 | MAPT (0.46) | ALDH1A1KMT2AMEN1NPC1NPSR1 | |
| SCHEMBL11767621 | 0.80 | KDM4E (0.70) | ALDH1A1KDM4EKMT2AMEN1NPC1 | |
| Acetic Acid SCHEMBL8132820 | 0.80 | MAPT (0.59) | ALDH1A1KMT2AMEN1NPC1PKM | |
| SCHEMBL10305757 | 0.77 | SIRT2 (0.47) | KMT2AMEN1NPC1MAPTLMNA | |
| SCHEMBL9652246 | 0.77 | ALOX5 (0.54) | ALDH1A1KMT2AMEN1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11117852-B2 | Isolation of pure cannabinoids from Cannabis | UNIVERSITY OF MISSISSIPPI (US) | 2021-09-14 | — | — | US | disclosed |
| US-20200039908-A1 | Isolation of pure cannabinoids from Cannabis | UNIVERSITY OF MISSISSIPPI | 2020-02-06 | — | — | US | disclosed |
| EP-3599831-A1 | ISOLATION OF PURE CANNABINOIDS FROM CANNABIS | University Of Mississippi (US) | 2020-02-05 | — | — | EP | disclosed |
| WO-2018187500-A1 | ISOLATION OF PURE CANNABINOIDS FROM CANNABIS | UNIVERSITY OF MISSISSIPPI (US) | 2018-10-11 | — | — | WO | disclosed |
| EP-1133688-A4 | METHOD OF PREPARING DELTA-9-TETRAHYDROCANNABINOL | UNIV MISSISSIPPI (US) | 2008-05-07 | — | — | EP | disclosed |
| US-7321047-B2 | Carbamoylating a tetrahydrocannabinol with an aryl or arylmethyl isocyanate or isothiocyanate, forming a solution of the (thio)carbamate in an organic solvent, separating the isomer of interest by crystallization, and hydrolyzing it to form the desired tetrahydrocannabinol isomer. | ALPHORA RESEARCH INC. (CA) | 2008-01-22 | — | — | US | disclosed |
| US-20060264647-A1 | Separation of tetrahydrocannabinols | SANDOZ INC. | 2006-11-23 | — | — | US | disclosed |
| EP-1472514-A4 | METHOD OF PREPARING DELTA-9 TETRAHYDROCANNABINOL | UNIV MISSISSIPPI (US) | 2006-01-04 | — | — | EP | disclosed |
| EP-1472514-A2 | METHOD OF PREPARING DELTA-9 TETRAHYDROCANNABINOL | University of Mississippi (US) | 2004-11-03 | — | — | EP | disclosed |
| US-6730519-B2 | ISOLATION TETRAHYDROCANNIBINOL FROM PLANT EXTRACT; OBTAIN PLANT SAMPLE, CHELATE TETRAHYDROCANNIBINOL TO SOLID SUPPORT, ELUTE AND RECOVER TETRAHYDROCARBANNIOL FROM SUPPORT | THE UNIVERSITY OF MISSISSIPPI | 2004-05-04 | — | — | US | disclosed |
| WO-2003061563-A2 | METHOD OF PREPARING DELTA-9 TETRAHYDROCANNABINOL | UNIVERSITY OF MISSISSIPPI (US) | 2003-07-31 | — | — | WO | disclosed |
| US-20020086438-A1 | Method of preparing delta-9-tetrahydrocannabinol | UNIVERSITY OF MISSISSIPPI, THE | 2002-07-04 | — | — | US | disclosed |
| US-20020039795-A1 | Recovering preferential particle from plants; obtain plant, generate extract, remove solvent from extract, expose extract to flash distillation, recover preferential plant particles | ELSOHLY ET AL | 2002-04-04 | — | — | US | disclosed |
| US-6365416-B1 | EFFICIENT AND ECONOMIC LARGE SCALE PRODUCTION BY SOLVENT EXTRACTION OF CANNABIS WITH NONPOLAR SOLVENT THEN CHROMATOGRAPHY AND VACUUM DISTILATION | THE UNIVERSITY OF MISSISSIPPI | 2002-04-02 | — | — | US | disclosed |
| EP-1133688-A1 | METHOD OF PREPARING DELTA-9-TETRAHYDROCANNABINOL | The university of Mississippi (US) | 2001-09-19 | — | — | EP | disclosed |
| WO-2000025127-A1 | METHOD OF PREPARING DELTA-9-TETRAHYDROCANNABINOL | THE UNIVERSITY OF MISSISSIPPI (US) | 2000-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039908-A1 | Isolation of pure cannabinoids from Cannabis | CNR2, CNR1, FAAH | ALDH1A1 4671/4885KDM4E 876/4885KMT2A 2821/4885 |
| US-20060264647-A1 | Separation of tetrahydrocannabinols | CNR2, CNR1, CBR1 | ALDH1A1 2232/4885KDM4E 1307/4885KMT2A 1788/4885 |
| US-11117852-B2 | Isolation of pure cannabinoids from Cannabis | CNR2, CNR1, FAAH | ALDH1A1 4671/4885KDM4E 876/4885KMT2A 2821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.